The use of IT has proven to be a great advantage in the processing of transplant applications and improves the chances of waiting patients. A crucial element in the transplantation process is the compatibility between donor and recipient. HLA, human leukocyte antigens, play a key role in organ transplants and are crucial for compatibility.
Clinisys™ is presenting its unique product Clinisys™ GLIMS HLA Transplant Module* for immunogenetics and HLA at the EFI conference. It can be used to support the data and process flow for next-generation analyses that integrate complex and high-resolution results. Clinisys™ GLIMS HLA Transplant Module is connected to national and European donor management databases such as Cristal, Syrenad and Eurotransplant via interfaces.
Interested in hearing more?
Visit us at stand 17 or make an appointment with our experts today:
- Stéphane Decap (Sr. Product Manager Genetics/HLA & Pathology)
- Philipp Breitensein (Sales Director Germany & Switzerland)
- or vertrieb@clinisys.com
www.clinisys.com